Skip to main
OFIX

Orthofix International (OFIX) Stock Forecast & Price Target

Orthofix International (OFIX) Analyst Ratings

Based on 4 analyst ratings
Buy
Strong Buy 50%
Buy 25%
Hold 25%
Sell 0%
Strong Sell 0%

Bulls say

Orthofix Medical is a medical device company that specializes in orthopedic and spine solutions. It has a strong global presence with two reportable segments, Global Spine and Global Limb Reconstruction, which offer a diverse range of products and solutions in their respective fields. The company's preliminary revenue report for Q1/26 exceeded expectations and management affirmed its 2026 financial guidance. However, there is a chance for higher litigation and investigation costs related to ongoing litigation connected to ex-Orthofix executives, which may impact profitability in the short term. Overall, the company remains well-positioned for growth with solid cash flow and manageable leverage levels, making it a good investment option with an OUTPERFORM rating.

Bears say

Orthofix Medical is facing a negative outlook due to uncertainties in the impacts of Medicare pricing on its bone growth stimulation business and potential failure to meet revenue or earnings estimates. This is compounded by the company's reliance on its global spine segment, which accounts for 84% of revenue and recent streamlining activities within its leadership team. These factors suggest potential challenges for the company's overall financial performance in the future.

Orthofix International (OFIX) has been analyzed by 4 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 25% recommend Buy, 25% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Orthofix International and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Orthofix International (OFIX) Forecast

Analysts have given Orthofix International (OFIX) a Buy based on their latest research and market trends.

According to 4 analysts, Orthofix International (OFIX) has a Buy consensus rating as of Aug 14, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $14.75, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $14.75, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Orthofix International (OFIX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.